Both in Biotechnology
Moderna vs Biogen
Over the past year MRNA returned +678.8% and BIIB returned +65.1%; their daily moves had a correlation of 0.25.
MRNA +678.8% BIIB +65.1%Growth of $1, one year, split-adjusted
| Metric | MRNA | BIIB |
|---|---|---|
| Price | $197.28 | $228.69 |
| Market cap | $78.76B | $33.79B |
| Today | −0.80% | +0.48% |
| 1 month | +38.2% | +3.2% |
| 6 months | +298.1% | +24.4% |
| Year to date | +569.0% | +29.9% |
| 1 year | +701.6% | +68.6% |
| Revenue growth (YoY) | +2.1% | +3.4% |
| Gross margin | 35.9% | 71.6% |
| Net margin | −539.3% | 3.6% |
| P/E (TTM) | — | 40.5× |
| Price / sales | 35.4× | 3.4× |
| Net cash | $4.54B | -$6.81B |
| Dividend yield | — | — |
| Volatility (60d) | 227.6% | 36.0% |
| Short % of float | 9.1% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).